We simplify complex diabetes data, generating simple, clear insights to empower clinics, healthcare professionals, and individuals with diabetes to make better informed decisions. Our mission fosters targeted patient focus, enhances treatment strategies, and cultivates deeper understanding and empowerment for individuals managing diabetes. We aspire to help the global diabetes population utilize this novel approach as the global standard of care for diabetes management.
We aim to revolutionize diabetes and pre-diabetes management worldwide, using state-of-the-art technology, leveraging AI/Machine Learning alongside Continuous Glucose Monitoring (CGM) to improve accessibility, effectiveness, and outcomes for patients globally.
The company was founded in 2019 in Stockholm and was then accepted into the Karolinska Institute DRIVE incubator program. Among the co-founders are the Professor of Medicine and Senior Consultant in diabetes, Per-Ola Carlsson (MD PhD) and the Associate Professor of Medicine and Senior Consultant, Daniel Espes (MD PhD), from Uppsala University. Per-Ola Carlsson is the Chief Medical Officer (CMO) and Daniel Espes is the Chief Scientific Officer (CSO) of OneTwo Analytics. Today, OneTwo Analytics consists of a versatile team with expertise in medical technology, clinical development, regulations, artificial intelligence, machine learning, design and healthcare management.
